<DOC>
	<DOCNO>NCT02077062</DOCNO>
	<brief_summary>Prospective non-randomized trial study expression mediator post hepatectomy liver regeneration ( PHLR ) compare non-hepatectomy group : pilot study Background : Experimental study use post hepatectomy animal model use study mechanism liver regeneration . Hepatectomy various disease live donor liver transplant provide good human model study vivo mechanism liver regeneration . These study necessary clinical application knowledge obtain animal experiment guide research develop new modality management hepatic failure , cirrhosis cancer . Null hypothesis : Expression mediator post hepatectomy liver regeneration ( PHLR ) different hepatectomy ( study group ) non hepatectomy group ( control group ) . Aim : To study mechanism post hepatectomy liver regeneration ( PHLR ) compare expression mediator PHLR hepatectomy ( study group ) non-hepatectomy group ( control group ) . Patient method : This prospective non randomize trail conduct two group patients- hepatectomy ( Study ) group non-hepatectomy ( control ) group minimum 10 consecutive adult ( 18 year ) patient recruit group accord inclusion exclusion criterion give . Informed consent obtain patient group . Peripheral ( forearm vein ) venous blood ( 6 ml ) collect day surgery different interval surgery ( day 1 , day 3,7 , 2 week , 6 week 6 month ) . A small branch portal vein cannulate 20 gauge intravenous catheter measurement portal pressure collection portal venous blood ( 6 ml ) start ( entry inside abdomen ) end ( closure abdomen ) . Patients hepatectomy ( study ) group undergo trucut ( needle ) biopsy remnant liver . Mediators liver regeneration measure standard method blood sample group . The liver tissue study group also analyse factor related initiation PHLR .</brief_summary>
	<brief_title>Study Mediators Post Hepatectomy Liver Regeneration</brief_title>
	<detailed_description>Prospective non-randomized trial study expression mediator post hepatectomy liver regeneration ( PHLR ) compare non-hepatectomy group : pilot study Background : Experimental study use post hepatectomy animal model use study mechanism liver regeneration . Hepatectomy various disease live donor liver transplant provide good human model study vivo mechanism liver regeneration . These study necessary clinical application knowledge obtain animal experiment guide research develop new modality management hepatic failure , cirrhosis cancer . Introduction : Liver vital organ serve various metabolic protective function necessary maintenance life get inherent potential regenerate restore volume partial resection . Liver regeneration hepatectomy occur mainly proliferation mature hepatocytes ( Fausto N 2003 &amp; 2004 ) ; change portal haemodyanmics cytokine ( IL-6 , TNF- α ) consider important trigger factor process . ( Abhshagen K et al 2012 , Scotte M et al 1997 ) It propose increase delivery portal blood remnant liver produce shear stress injury lead release factor like NO VEGF activate regeneration cascade ( Marabushi et al 2004 ) . Cytokines ( IL-6 TNF-α ) , NO VEGF act pro HGF ( inactive hepatocyte growth factor ) convert active HGF act Met receptor activate STAT-3 key mediator early phase PHLR . ( Abhshgen K et al 2008 , Cresman DE et al 1996 , Cressman DE1997 , Sudo K et al 2008 , Borowicak M et al 2004 , Paranjpe S et al 2007 ) Increased delivery portal blood remnant liver also increase per unit availability amino acid , pancreatic hormone , gut derive endotoxin hepatotrophic factor , may act directly activate DNA replication . ( Bucher NL et al 1977 , Riehle KJ et al 2011 ) Administration amino acid mixture intact rat induces wave hepatocyte replication , deprivation block PHLR . ( Mead JE et al 1990 ) Insulin , Glucagon Growth hormone also significant impact liver regeneration . ( Bucher NLR 1976 , Shi min luo et al 2004 , Amal ZS et al 2011 ) The capability liver regenerate partial resection permit u perform hepatectomy live donor liver transplantation , hepatic neoplasm biliary cancer . Hepatectomy condition also provide u good model study vivo mechanism liver regeneration human being . These study important clinical application knowledge obtain experimental study post hepatectomy animal . These study help u know mediator various phase post hepatectomy liver regeneration ( PHLR ) guide future research develop new approach prevention management life threaten post hepatectomy complication like `` Small size syndrome '' , hepatic failure . These trail help understand vivo control cellular proliferation may prove vital develop new therapeutic approach treat cirrhosis cancer . Null hypothesis : Expression mediator post hepatectomy liver regeneration ( PHLR ) different hepatectomy ( study group ) non hepatectomy group ( control group ) . Aim : To study mechanism post hepatectomy liver regeneration ( PHLR ) compare expression mediator PHLR hepatectomy ( study group ) non-hepatectomy group ( control group ) . Objectives : 1 . To study mediator PHLR human model . 2 . To compare expression mediator PHLR hepatectomy ( study group ) non hepatectomy ( control group ) . 3 . To study initial change PHLR liver tissue . Patient method : This prospective non randomize trail conduct two group patients- hepatectomy ( Study ) group non-hepatectomy ( control ) group minimum 10 consecutive adult ( 18 year ) patient recruit group accord inclusion exclusion criterion give . Informed consent obtain patient group . Peripheral ( forearm vein ) venous blood ( 6 ml ) collect day surgery surgery post operative day 1 , 3,7 , 14 ( 2 week ) , 42 ( 6 week ) 180 ( 6 month ) . A small branch portal vein cannulate 20 gauge intravenous catheter measurement portal pressure collection portal venous blood ( 6 ml ) start surgery entry inside abdomen end surgery closure abdomen . Collection blood sample peripheral vein ( forearm vein ) , measurement portal pressure collection portal blood do study group patient hepatectomy ( study ) group undergo additional procedure i.e trucut ( needle ) biopsy remnant liver . Liver biopsy specimen preserve formalin solution transfer pathology lab detect initial change PHLR possible mediator , normal liver tissue present resect specimen serve self control . Blood peripheral vein small branch portal vein collect standard vial use purpose transferred laboratory analysis detect mediator liver regeneration . The analysis blood sample do use ELISHA method . Measurement portal pressure do canulation small branch portal vein ( e.g . Gastro epiploic vein ) entry inside vein intravenous catheter connect digital pressure recorder via connect tube fill normal saline . This digital pressure recorder available anaesthesia work station ( Make : Drager ) usually give measurement mm Hg , pressure record do surgery observe effect surgery portal pressure . Inclusion criterion : Adult patient ( 18 year ) malignant neoplasms gastrointestinal tract require either partial resection liver ( study group ) resection part gastrointestinal tract ( control group ) willing participate study . Exclusion criteria- Patients willing participate study . Patients condition affect expression mediator PHLR ( e.g . immunosuppression , chronic hepatitis , cirrhosis , portal hypertension , pregnancy , contraceptive use ) , patient find advance inoperable disease surgery exclude study data collect included analysis . Sample size : Minimum 10 patient group Design : prospective non randomize trail Place study : Department Gastrointestinal surgery , GBPH MAMC , New Delhi Duration : 2 year . Follow Up : 6 month Funding : The investigator apply funding government agency . Mediator PHLR analyse peripheral blood ELISA method - IL-1 IL-6 , T N F-α , TNF-β , HGF ( hepatocyte growth factor ) , GH ( growth hormone ) , Insulin Glucagon . Examination liver biopsy specimen ( Immunohistochemistry ) : mitotic index ( Ki 67 ) , EPCAM , STAT-3 , receptor HGF , VEGF , NKAM CD133 . Statistical method : All data enter Microsoft excel statistical calculation perform use SPSS software . In order compare mean expression various tissue factor liver tissue hepatectomy investigator shall use paired test distribution variable normal Wilcox-on sign rank test non normal distribution . For compare expression mediator liver regeneration serum patient study control group investigator shall use independent test normal distribution Mann Whitney test non normal distribution . In order study average serum level mediator liver regeneration different point time surgery investigator shall use ANOVA normal distribution Friedman test non normal distribution follow post hoc test . P value 0.5 use derive significance . Literature review : Liver regegenration hepatectomy complex orderly process involve proliferation mature hepatocytes regain liver volume , exact mechanism liver regeneration unfold till evidence base animal research ( rat , mouse , dog etc ) indicate acute change portal haemodynamics , cytokine , growth factor ( HGF , TGF , EGF ) , hormone ( like GH , Insulin , adrenaline ) actively involved process control hundred gene . ( Fausto N 2012 Michelopoulos 2010 ) Marabushi et al ( 2004 ) propose acute increase amount portal blood delivery remnant liver produce shear stress injury lead production nitric oxide ( NO ) , activation calcium channel release VEGF ; play key role initiation regeneration process . Bucher NL ( 1964 ) observe haemodynamic change portal blood flow directly relate extent hepatectomy , increase portal pressure 90 % hepatectomy much high 70 % hepatectomy . Sato et al ( 1997 &amp; 1999 ) reconfirm finding Bucher NL also observe progressive increase portal pressure liver regeneration progress decline towards completion . Experimental study various researcher like Wang Lautt ( 1998 ) , Cantre D et al ( 2008 , ) Schoen JM et al ( 2001 ) Mei Y et al ( 2011 ) confirm role NO activation factor responsible hepatocyte proliferation . VEGF release sinusoidal endothelium response shear stress injury stimulate HGF ( hepatocyte growth factor ) act c-met receptor initiate hepatocytes proliferation . ( Paranjpe S et al 2007 , Borowiak M et al 2004 ) Portal hypertension associate cirrhosis n't lead shear stress associate injury due capillarization sinusoidal endothelial cell ( SECs ) loss sieve plate . ( Sato et al 1997 &amp; Vollmer et al 1998 ) . Suenaga M ( 1983 ) study role portal blood liver regeneration partial hepatectomy dog notice adequate amount portal blood necessary hepatic regeneration high concentration amino acid portal blood positive impact regeneration process . In another study Skov OP et al ( 1988 ) note portal blood contains high amount EGF ( epidermal growth factor ) , pancreatic hormone ( Insulin , glucagon ) growth factor participate actively liver regeneration . Bucher NL ( 1976 1977 ) observe Insulin glucagon facilitate liver regeneration DNA synthesis hepatectomy non- portal factor require fail induce hepatocyte proliferation intact liver induce hepatocyte proliferation hepatectomized eviscerated rat . In addition two ( Insulin Glucagon ) hormone like Growth hormone , Nor adrenaline , serotonin etc also participate process . ( Amal ZS et al,2011 ; Shi Min Luo , 2004 ) IL-6 TNF-α two factor vital initiation PHLR , portal blood contains gut derived factor like lipopolysaccharides , complement factor , intercellular adhesion molecule activate Kupffer cell release IL-6 TNF-α act paracrine manner initiate regeneration . ( Fausto N 2006 , Michelopoulos 2007 , Cressman DE et al 1996 , Feingold KR et al 1988 , Sudo K et al 2008 , Yamada Y et al 1997 , Cornell RP et al 1985 ) . Il-6 , TNF-α , VEGF , NO initiate regeneration activate HGF ( hepatocyte growth factor ) potent hepatocyte mitogen . ( Diaz JJ et al 2011 , Cantre D et al 2008 , Rai RM et al 2005 ) . HGF along epidermal growth factor ( EGF ) , fibroblast growth factor ( FGF ) , transform growth factor ( TGF ) , hepatotrophic hormone , several know unknown factor control hepatocyte proliferation propagation . ( Fausto N 1993 , Fausto N Mead JE 1989 ) .HGF bind Met receptor hepatocytes activate growth proliferation . ( Borowick et al 2004 ) HGF , EGF TGF alfa potent vitro mitogens induce hepatocyte proliferation normal liver even absence factor presence factor like cytokine stimulate proliferation significant proportion hepatocytes . ( Block GD et al 1996 , Webber EM et al 1998 ) TGF-α induce DNA synthesis c-myc expression add rat hepatocyte culture . ( Skouteris GG Menamin MM 1992 ) Inflammatory mediator like Prostaglandin ( PGE-2 ) also play role liver regeneration level increase hepatectomy rat , process dependent c-AMP ; addition prostaglandins hepatocyte culture find increase DNA synthesis . ( Tsujii H et al , 1993 ) EGF stimulate neonatal rat hepatocyte primary culture enter S M phase , detect early 4 hour peak 12 16 hour thereafter decline effect modulate serum factor administration glucagon insulin amplifies growth . ( Draghi E et al , 1980 ) HGF considerable role PHLR , bind meet receptor activates STAT-3 ( signal transducer activator transcription 3 ) mediate induction early response gene Met mutant mouse show impaired liver regeneration . ( Borowiak M et al 2004 ) Huh CG et al 2004 study Met mutant mouse show HGF/C-Met signal pathway play central role development , liver regeneration tumorigenesis . HGF/Met pathway regulate expression many gene relate cell cycle apoptosis , include p53 , cyclin E , cyclin B , order promote cell cycle inhibit apoptosis 24 hour follow partial hepatectomy . ( Paranjpe S et al 2007 ) STAT-3 ( signal transducer activator-3 ) transcription factor regulate various primary growth response gene hepatectomy activate various growth factor cytokine . ( Li W et al 2002 ) STAT -3 DNA bind activity increase remnant liver within 30 minute PH ( partial hepatectomy ) peak 30 fold within 3 hour increase occur sham surgery . ( Cressman DE et al , 1995 ) Several proto-oncogene also involved initiation completion liver regeneration , c-fos , c-jun c-myc important gene . C-fos c-jun transcript level increase liver almost immediately hepatectomy return normal 2 hour . This followed elevation c-myc RNA reach peak 2 hour dip basal level 4hours . ( Fausto N et al 1989 ; Morello D , 1989 ) In study Morello D et al ( 1990 ) find Increase c-myc RNA hepatectomy many fold high sham surgery . In addition factor mention several cell like Oval cell , Macrophages , Platelets Stem cell ( CD133+ ) also participate PHLR directly indirectly . ( Evarts RP et al 1987 , Nakamura T et al 1986 , Fausto N 2004 , Xiang S et al 2012 ) In study amEsch JS ( 2012 ) CD 133+ stem cell infusion improve hepatic reserve overall outcome extend hepatectomy . T-cells also affect liver regeneration mouse deficient T-cell lymphotoxin decrease capability liver regeneration . ( Anders SA et al 2005 , Tumanov AV et al 2009 ) Oval cell less sensitive inhibition TGF-beta , significantly inhibit proliferation mature hepatocytes cell ( oval cell ) provide alternative route liver regeneration . ( Lenanh NN et al 2007 ) TGF beta inhibitor uncontrolled heaptocyte proliferation TGF beta RNA expression reach peak towards completion cell division mitosis , also inhibitory effect EGF activity . ( Nquyen LN et al 2007 , Braun L et al , 1988 , Fausto N et al 1990 ) . In study Romero GJ et ( 2005 ) TGF beta receptor knockout heptectomized mouse show increase hepatocyte proliferation increase liver mass body ratio . Scotte M et al ( 1997 ) study cytokine expression liver follow minor major hepatectomy rat find TNF IL-1 increase minor major hepatectomy IL-6 regulation prominent major ( 80 % ) hepatectomy . Li J et al ( 2009 ) compare regeneration profile major ( 2/3rd ) minor ( 1/3rd ) hepatectomy rat , gene expression profile 4 , 12 , 30 hour hepatectomy show similar regulation although gene show preferential expression major hepatectomy . Masson S et al ( 1999 ) also study impact extent resection liver regeneration rat conclude regenerative response occur whatsoever extent hepatectomy course regeneration expression growth factor differs accord volume resect liver . M Nagino et al ( 2011 ) observe liver regenerates rapidly first two week major hepatectomy thereafter progress slowly stops reach 3/4th original liver volume , usually occur 6 month 1 year hepatectomy . They also notice factor like extent resection , body surface area , portal vein resection , portal vein emobilisation ICG clearance associate regenerate liver volume hepatectomy .</detailed_description>
	<criteria>adult ( 18 year ) hepatectomy malignant neoplasm ( study group ) GI resection malignant G I tract tumor willing participate less 18 year age willing participate immunosuppression chronic hepatitis cirrhosis portal hypertension pregenancy oral contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>hepatectomy ,</keyword>
	<keyword>liver regeneration</keyword>
	<keyword>mediator</keyword>
</DOC>